ScienceDaily (Oct. 18, 2007) — Mammography continues to be the method of choice for the early detection of breast cancer. However, because this technique is not as selective or specific as one would wish, and does not deliver reliable results for every level of tissue density, alternatives are being sought. Near-infrared fluorescence mammography, which works with rays of near-infrared (NIR) light instead of X-rays, is a highly promising technique—although effective contrast agents have thus far been lacking.

A team led by John V. Frangioni at the Beth Israel Deaconess Medical Center of the Harvard Medical School in Boston, Massachusetts, has developed a contrast agent that makes visible the microcalcifications related to malignant breast tumors. The researchers report in the journal Angewandte Chemie that in validation trials in swine their new contrast agent distinguishes specific calcium salts in soft tissues, as well as depicting bones.

As breast cancer develops, calcium salts are deposited in breast tissue. These microscopic calcium deposits consist mostly of hydroxyapatite, a salt containing calcium and phosphate that is also present in bones.

As the basis of their NIR contrast agent, the researchers chose to use the osteoporosis drug pamidronate, a biphosphonate. Biphosphonates, which are also used for the treatment of bone metastases in breast cancer patients, preferentially bind to bone. Frangioni and his team attached a dye that both absorbs light and fluoresces in the NIR region of the spectrum to a pamidronate derivative. Light in this region of the spectrum penetrates especially well into living tissue without damaging it, and is also easy to detect.

Thanks to a simplified, reliable synthetic route to a new pamidronate derivative developed by Kumar R. Bhushan, the American team has now been able to synthesize large quantities of a contrast agent called Pam800—enough to run a trial with large animals. Pigs are particularly well suited to such trials because their organs are of approximately the same size as human organs.

As confirmed by surgical incisions, intravenously administered Pam800 reveals the bones of pigs with very high sensitivity. When hydroxyapatite is injected into the soft tissues, the contrast agent marks only the tiny hydroxyapatite crystals with high selectivity and sensitivity. This could allow it to selectively reveal malignant abnormal tissue. The swine trials demonstrated that the use of real-time NIR fluorescence images even make possible image-guided surgery of the soft tissues and bones.

Reference: Synthesis of Conjugatable Bisphosphonates for Molecular Imaging of Large Animals, Angewandte Chemie International Edition 2007, 46, 7969–7971 doi: 10.1002/anie.200701216

Story Source:

Adapted from materials provided by John Wiley & Sons, Inc..

Related Stories

Contrast Agent Puts New Light On Diagnosing Breast Cancer (Apr. 3, 2007) — Scientists have developed a contrast agent that selectively targets and highlights malignant micro-calcifications in the breast, while ignoring similar micro-calcifications found in benign breast ...  > read more

Researchers Fine-Tune Diffuse Optical Tomography For Breast Cancer Screening (Oct. 6, 2009) — Researchers are working to make the physical pain and discomfort of mammograms a thing of the past, while allowing for diagnostic imaging eventually to be done in a home ...  > read more

Breast Cancer Diagnosis From Combined MRI-Optics Method (Apr. 15, 2007) — By combining two techniques, magnetic resonance imaging (MRI) and near-infrared optics, scientists may have devised a new, potentially more accurate method for diagnosing breast ...  > read more

Cone-Beam CT Faster, Potentially More Accurate Than Conventional Mammography (Jan. 1, 2008) — Cone-beam breast CT provides exceptional tissue contrast and can potentially reduce examination time with comparable radiation dose to conventional 2D mammography, according to a new study. Cone-beam ...  > read more

Switch To Digital Mammography Leads To Increased Cancer Detection Rates (Aug. 3, 2009) — The use of digital mammography equipment alone is responsible for an increased number of breast cancers detected at a community-based mammography facility, according to a new ...  > read more

Search ScienceDaily

Pain Free Mammogram